Estradiol
Product Images NDC 53002-1808

Product Visual Gallery

This gallery contains 17 technical images submitted to the FDA as part of the official labeling for Estradiol (NDC 53002-1808). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Estradiol Structural Formula (Image 01)

Chemical structure of estradiol, showing its steroid core with hydroxyl and methyl functional groups as characteristic features of this active ingredient.*

FDA Label Image

Estradiol Transdermal System (Layers)

Label for Estradiol tablets packaged by RPK Pharmaceuticals, Inc. The label is grayscale with horizontal lines and patterns but does not show any legible text about strength, dosage form, or quantity.*

FDA Label Image

Figure 1 Steady-state Estradiol Plasma Concentrations For Systems Applied To The Abdomen (Image 03)

A line graph showing concentration (pg/mL) over time (days) for Estradiol at different dosages: 0.1 mg/day, 0.075 mg/day, 0.05 mg/day, and 0.0375 mg/day. Each dosage is represented by distinct symbols and lines, displaying concentration changes across approximately 4 days.*

FDA Label Image

Figure 2 Mean (sd) Change From Baseline In Mean Daily Number (Image 04)

A bar graph showing mean (SD) reduction from baseline over 12 weeks comparing Estradiol 0.0375 mg/day and placebo. Data is shown at Weeks 4, 8, and 12, with Estradiol bars consistently lower indicating greater reduction. Statistically significant differences (p<0.05) between estradiol and placebo are noted at each time point.*

FDA Label Image

Figure 3 Bone Mineral Density (Image 05)

A line graph depicting percentage change from baseline over treatment duration in weeks (26, 52, 78, and 104). It compares Estradiol doses of 0.1 mg/day, 0.05 mg/day, 0.0375 mg/day, 0.025 mg/day, and placebo. Each dose is represented by a different line style or marker, showing trends in response over time.*

FDA Label Image

Figure 4 Bone Mineral Density (Image 06)

A line chart showing percent change from baseline over treatment duration up to week 104 for Estradiol doses 0.1 mg/day, 0.05 mg/day, 0.0375 mg/day, 0.025 mg/day, and placebo. The chart includes statistical significance markers comparing Estradiol groups to placebo at different weeks.*

FDA Label Image

Estradiol Transdermal System (Calendar)

An instructional diagram for the Estradiol Transdermal System showing guidance to change the patch only on specified two-day combinations: Sun/Wed, Mon/Thu, Tue/Fri, Wed/Sat, Thu/Sun, Fri/Mon, and Sat/Tue.*

FDA Label Image

Where To Apply Estradiol Transdermal System (Image 08)

An illustration showing a close-up of a person's abdomen with a hand applying a transdermal patch. The patch is positioned below the navel, indicating typical placement for transdermal delivery.*

FDA Label Image

Before You Apply Estradiol Transdermal System (Image 09)

FDA Label Image

Hows To Apply Estradiol Transdermal System (1)

Illustration showing a hand peeling a clear protective film or adhesive backing from a rectangular patch or label held by the other hand. The image appears instructional, demonstrating how to remove the backing from the product before application or use.*

FDA Label Image

How To Apply Estradiol Transdermal System (2)

An instructional illustration showing two hands peeling or separating a small rectangular strip or patch, demonstrating the correct way to open or handle the product packaging.*

FDA Label Image

How To Apply Estradiol Transdermal System (3)

Illustration showing a hand holding a capsule near a person's exposed abdomen, likely demonstrating how to place or apply the capsule in that area.*

FDA Label Image

How To Apply Estradiol Transdermal System (4)

An instructional illustration showing a person applying a transdermal patch to the back of a hand using the other hand. The image depicts the proper placement or application technique for a patch-based medication delivery system.*

FDA Label Image

How To Apply Estradiol Transdermal System (5)

An instructional diagram showing a person removing a fingernail or applying a small adhesive strip or patch to the fingertip of another hand. The illustration focuses on the hands and the action involving the fingertip, likely related to medication administration or sample collection.*

FDA Label Image

How To Apply Estradiol Transdermal System (6)

An instructional line drawing depicting a hand approaching the lower abdomen area of a person. This figure likely illustrates the site of application or action for the medication Estradiol by RPK Pharmaceuticals, Inc.*

FDA Label Image

How To Apply Estradiol Transdermal System (7)

An instructional illustration showing a hand applying a small adhesive patch on the lower abdominal area, likely demonstrating how to apply an estradiol transdermal patch.*

FDA Label Image

Label Image (Lbl530021808)

Packaging label for Estradiol Transdermal System 0.1mg (twice weekly) containing 8 patches. The label shows instructions to apply the patch twice weekly as directed, with spaces for patient and prescriber names. The product is from RPK Pharmaceuticals, Inc. and includes NDC code 53002-1808.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.